ATE344026T1 - Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant - Google Patents

Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant

Info

Publication number: ATE344026T1
Authority: AT; Austria
Prior art keywords: renin inhibitor; surfactant; pharmaceutical formulation; formulation containing; physiologically tolerated
Prior art date: 2002-06-28

Application number

AT03761592T

Other languages

English (en)

Inventor

Jutta Riedl

Satish Kannah

Walter Dieterle

Original Assignee

Speedel Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-28

Filing date

2003-06-25

Publication date

2006-11-15

2003-06-25 Application filed by Speedel Pharma Ag filed Critical Speedel Pharma Ag

2006-11-15 Application granted granted Critical

2006-11-15 Publication of ATE344026T1 publication Critical patent/ATE344026T1/de

Links

239000002461 renin inhibitor Substances 0.000 title abstract 4
229940086526 renin-inhibitors Drugs 0.000 title abstract 4
239000004094 surface-active agent Substances 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title 1
239000000203 mixture Substances 0.000 abstract 4
239000002280 amphoteric surfactant Substances 0.000 abstract 1
239000003945 anionic surfactant Substances 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

AT03761592T 2002-06-28 2003-06-25 Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant ATE344026T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH11242002		2002-06-28

Publications (1)

Publication Number	Publication Date
ATE344026T1 true ATE344026T1 (de)	2006-11-15

Family

ID=29783980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03761592T ATE344026T1 (de)	2002-06-28	2003-06-25	Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant

Country Status (11)

Country	Link
US (1)	US20050147629A1 (de)
EP (1)	EP1517682B1 (de)
JP (1)	JP4519640B2 (de)
AT (1)	ATE344026T1 (de)
AU (1)	AU2003255527A1 (de)
CY (1)	CY1105934T1 (de)
DE (1)	DE60309472T2 (de)
DK (1)	DK1517682T3 (de)
ES (1)	ES2276110T3 (de)
PT (1)	PT1517682E (de)
WO (1)	WO2004002466A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200513461A (en) *	2003-10-01	2005-04-16	Speedel Experimenta Ag	Organische verbindungen
BRPI0506491A (pt) *	2004-01-23	2007-02-13	Speedel Experimenta Ag	compostos orgánicos
ATE472524T1 (de) *	2004-01-23	2010-07-15	Novartis Ag	Diaminoalkohole und deren verwendung als renininhibitoren
AR048431A1 (es) *	2004-03-17	2006-04-26	Novartis Ag	Formulaciones galenicas de compuestos organicos
US20070191487A1 (en) *	2004-03-17	2007-08-16	Rigassi-Dietrich Petra G	Galenic formulations of organic compounds
PE20060416A1 (es) *	2004-08-03	2006-06-09	Novartis Ag	Composicion de inhibidores de renina e inhibidores de proteinas de efusion
EP1707202A1 (de) *	2005-03-31	2006-10-04	Speedel Experimenta AG	Organische Verbindungen
EP2062874B1 (de)	2007-11-20	2014-12-17	KRKA, tovarna zdravil, d.d., Novo mesto	Verfahren und Zwischenprodukte für die Herstellung von Aliskiren
EP2143425A1 (de)	2008-07-11	2010-01-13	Ratiopharm GmbH	Direktverpresste Aliskiren-Tabletten
SI2189442T1 (sl)	2008-11-20	2015-03-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	Postopek in intermediati za pripravo aliskirena

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0031603A1 (de) *	1979-12-31	1981-07-08	American Cyanamid Company	Pharmazeutische Zusammensetzung eines Grundstoffs
IE68045B1 (en) *	1990-05-11	1996-05-15	Abbott Lab	Renin inhibitors
US5523289A (en) *	1991-04-15	1996-06-04	Abbott Laboratories	Pharmaceutical composition
WO1993017681A1 (en) *	1992-03-02	1993-09-16	Abbott Laboratories	Angiotensin ii receptor antagonists
ES2154277T3 (es) *	1993-07-15	2001-04-01	Hoffmann La Roche	Combinacion farmaceutica que contiene un inhibidor del sistema renina-angiotensina y un antagonista de endotelina.
SE9503143D0 (sv) *	1995-09-12	1995-09-12	Astra Ab	New preparation
ZA9710927B (en) *	1996-12-06	1998-06-15	Fujisawa Pharmaceutical Co	Pharmaceutical composition.
US8168616B1 (en) *	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
UA80393C2 (uk) *	2000-12-07	2007-09-25	Алтана Фарма Аг	Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці

2003
- 2003-06-25 DE DE60309472T patent/DE60309472T2/de not_active Expired - Lifetime
- 2003-06-25 AU AU2003255527A patent/AU2003255527A1/en not_active Abandoned
- 2003-06-25 PT PT03761592T patent/PT1517682E/pt unknown
- 2003-06-25 DK DK03761592T patent/DK1517682T3/da active
- 2003-06-25 US US10/515,817 patent/US20050147629A1/en not_active Abandoned
- 2003-06-25 JP JP2004516786A patent/JP4519640B2/ja not_active Expired - Fee Related
- 2003-06-25 AT AT03761592T patent/ATE344026T1/de active
- 2003-06-25 ES ES03761592T patent/ES2276110T3/es not_active Expired - Lifetime
- 2003-06-25 EP EP03761592A patent/EP1517682B1/de not_active Expired - Lifetime
- 2003-06-25 WO PCT/EP2003/050266 patent/WO2004002466A1/en not_active Ceased
2007
- 2007-01-17 CY CY20071100066T patent/CY1105934T1/el unknown

Also Published As

Publication number	Publication date
JP4519640B2 (ja)	2010-08-04
DE60309472D1 (de)	2006-12-14
EP1517682B1 (de)	2006-11-02
DK1517682T3 (da)	2007-02-26
WO2004002466A1 (en)	2004-01-08
ES2276110T3 (es)	2007-06-16
AU2003255527A1 (en)	2004-01-19
PT1517682E (pt)	2007-02-28
CY1105934T1 (el)	2011-04-06
DE60309472T2 (de)	2007-06-28
EP1517682A1 (de)	2005-03-30
US20050147629A1 (en)	2005-07-07
JP2005533816A (ja)	2005-11-10

Similar Documents

Publication	Publication Date	Title
NO2025027I1 (no)	2025-06-13	Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
CY1105934T1 (el)	2011-04-06	Φαρμακευτικη συνθεση που αποτελειται απο αναστολεα πενινης μη πεπτιδιου και επιφανειοδραστικο παραγοντα
EP1708686A4 (de)	2007-12-26	Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
CY1120138T1 (el)	2018-12-12	Στερεη φαρμακευτικη μορφη δοσολογιας που περιλαμβανει μια στερεη διασπορα αναστολεα πρωτεασης toy hiv
YU69603A (sh)	2006-05-25	Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum
TR200001810A3 (tr)	2001-11-21	Hemen Eriyen Oral Dozaj Formülasyonu.
WO2004000197A3 (en)	2005-03-24	Quick dissolve compositions and tablets based thereon
DE60212819D1 (de)	2006-08-10	Salzformarme polyallylamine
EA200400471A1 (ru)	2004-10-28	Оральная дозированная форма пропиверина
TW200505406A (en)	2005-02-16	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
PT1131050E (pt)	2004-11-30	Formulacoes galenicas que se desintegram rapidamente na boca e metodo para as preparar
CA2484184A1 (en)	2005-04-11	Minoxidil foam formulation
ATE493973T1 (de)	2011-01-15	Irbesartan enthaltende pharmazeutische zusammensetzung
ATE437643T1 (de)	2009-08-15	Pharmazeutische zusammensetzung mit einem benzodiazepin-derivat und einem hemmer des rsv- fusionsproteins
MXPA05007609A (es)	2005-09-30	Antagonista de un receptor sensible al calcio.
DK1383752T3 (da)	2005-10-17	Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
HUP0301487A2 (hu)	2003-11-28	Piranon proteáz inhibitorok orális adagolású önemulgeáló formulációi
ATE464043T1 (de)	2010-04-15	Pharmazeutische zusammensetzung enthaltend l- arginin
MXPA04003540A (es)	2004-07-22	Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.
BR0206960A (pt)	2004-03-09	Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DE50105710D1 (de)	2005-04-28	Pharmazeutische, ramipril enthaltende brauseformulierung
SE0001916D0 (sv)	2000-05-23	Novel formulation
JP2005533816A5 (de)	2006-08-10
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex

Legal Events

Date

Code

Title

Description

2007-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1517682

Country of ref document: EP